GlassScriptPhysician profile
Terrence M Calder
NPI 1437124468
$1,651.66
in general payments reported to CMS, 2019-2025
18 companies · $387 in 2025
The $387 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $415 · 2020: $122 · 2021: $140 · 2022: $221 · 2023: $205 · 2024: $161 · 2025: $387.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $753.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $753.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $717.55 | 2019-2025 | Wavewriter Alpha Prime 16 |
| Collegium Pharmaceutical, INC. | $274.62 | 2020-2025 | Belbuca, Xtampza |
| Abbvie INC. | $145.86 | 2022-2024 | Botox |
| Averitas Pharma INC. | $84.77 | 2023-2025 | Qutenza |
| Allergan, INC. | $73.22 | 2019-2022 | |
| Biodelivery Sciences International, INC. | $68.54 | 2019-2020 | |
| Pfizer INC. | $62.87 | 2019-2020 | |
| Ibsa Pharma INC. | $37.41 | 2023-2025 | Tirosint, Licart, Flector |
| Abbott Laboratories | $32.39 | 2022-2023 | Proclaim |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $27.94 | 2019 | |
| Supernus Pharmaceuticals, INC. | $19.35 | 2019 | |
| Tactile Systems Technology INC | $17.95 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $17.58 | 2025 | |
| Grt US Holding, INC. | $17.11 | 2022 | |
| Daiichi Sankyo INC. | $15.16 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Electronic Waveform Lab, INC. | $14.16 | 2019 | |
| Medtronic USA, INC. | $14.04 | 2020 | |
| Forte Bio-Pharma LLC | $11.14 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Terrence Calder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.